Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression (original) (raw)

• Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004; 119: 941–953.
  Article CAS PubMed Google Scholar
• Lee MG, Wynder C, Cooch N, Shiekhattar R . An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 2005; 437: 432–435.
  Article CAS PubMed Google Scholar
• Huang Y, Marton LJ, Woster PM, Casero RA . Polyamine analogues targeting epigenetic gene regulation. Essays Biochem. 2009; 46: 95–110.
  Article CAS PubMed PubMed Central Google Scholar
• Lee M, Wynder C, Cooch N, Shiekhattar R . An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 2005; 437: 432–435.
  Article CAS PubMed Google Scholar
• Garcia-Bassets I, Kwon YS, Telese F, Prefontaine GG, Hutt KR, Cheng CS et al. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 2007; 128: 505–518.
  Article CAS PubMed PubMed Central Google Scholar
• Lim S, Janzer A, Becker A, Zimmer A, Schule R, Buettner R et al. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 2010; 31: 512–520.
  Article CAS PubMed Google Scholar
• Metzger E, Wissmann M, Yin N, Muller J, Schneider R, Peters A et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 2005; 437: 436–439.
  Article CAS PubMed Google Scholar
• Zhu Q, Huang Y, Marton LJ, Woster PM, Davidson NE, Casero RA Jr. . Polyamine analogs modulate gene expression by inhibiting lysine-specific demethylase 1 (LSD1) and altering chromatin structure in human breast cancer cells. Amino Acids 2012; 42: 887–898.
  Article CAS PubMed Google Scholar
• Huang Y, Greene E, Murray Stewart T, Goodwin AC, Baylin SB, Woster PM et al. Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes. Proc Natl Acad Sci U S A 2007; 104: 8023–8028.
  Article CAS PubMed PubMed Central Google Scholar
• Vasilatos SN, Katz TA, Oesterreich S, Wan Y, Davidson NE, Huang Y . Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells. Carcinogenesis 2013; 34: 1196–1207.
  Article CAS PubMed PubMed Central Google Scholar
• Serce N, Gnatzy A, Steiner S, Lorenzen H, Kirfel J, Buettner R . Elevated expression of LSD1 (Lysine-specific demethylase 1) during tumour progression from pre-invasive to invasive ductal carcinoma of the breast. BMC Clin Pathol 2012; 12: 13.
  Article PubMed PubMed Central Google Scholar
• Huang Y, Stewart TM, Wu Y, Baylin SB, Marton LJ, Perkins B et al. Novel oligoamine analogues inhibit lysine-specific demethylase 1 and induce reexpression of epigenetically silenced genes. Clin Cancer Res 2009; 15: 7217–7228.
  Article CAS PubMed PubMed Central Google Scholar
• Nowotarski SL, Pachaiyappan B, Holshouser SL, Kutz CJ, Li Y, Huang Y et al. Structure-activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures. Bioorg Med Chem 2015; 23: 1601–1612.
  Article CAS PubMed PubMed Central Google Scholar
• Mohammad HP, Smitheman KN, Kamat CD, Soong D, Federowicz KE, Van Aller GS et al. A DNA hypomethylation signature predicts antitumor activity of LSD1 inhibitors in SCLC. Cancer Cell 2015; 28: 57–69.
  Article CAS PubMed Google Scholar
• Yang XJ, Gregoire S . Class II histone deacetylases: from sequence to function, regulation, and clinical implication. Mol Cell Biol 2005; 25: 2873–2884.
  Article CAS PubMed PubMed Central Google Scholar
• Martin M, Kettmann R, Dequiedt F . Class IIa histone deacetylases: regulating the regulators. Oncogene 2007; 26: 5450–5467.
  Article CAS PubMed Google Scholar
• McKinsey TA, Zhang CL, Lu J, Olson EN . Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 2000; 408: 106–111.
  Article CAS PubMed PubMed Central Google Scholar
• Martin M, Kettmann R, Dequiedt F . Class IIa histone deacetylases: conducting development and differentiation. Int J Dev Biol 2009; 53: 291–301.
  Article CAS PubMed Google Scholar
• Santner SJ, Dawson PJ, Tait L, Soule HD, Eliason J, Mohamed AN et al. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10 AT cells. Breast Cancer Res Treat 2001; 65: 101–110.
  Article CAS PubMed Google Scholar
• Wu Y, Wang Y, Yang XH, Kang T, Zhao Y, Wang C et al. The deubiquitinase USP28 stabilizes LSD1 and confers stem-cell-like traits to breast cancer cells. Cell Rep 2013; 5: 224–236.
  Article CAS PubMed PubMed Central Google Scholar
• Han X, Gui B, Xiong C, Zhao L, Liang J, Sun L et al. Destabilizing LSD1 by Jade-2 promotes neurogenesis: an antibraking system in neural development. Mol Cell 2014; 55: 482–494.
  Article CAS PubMed Google Scholar
• Huang Y, Nayak S, Jankowitz R, Davidson NE, Oesterreich S . Epigenetics in breast cancer: what's new? Breast Cancer Res 2011; 13: 225.
  Article CAS PubMed PubMed Central Google Scholar
• Abukhdeir AM, Park BH . P21 and p27: roles in carcinogenesis and drug resistance. Expert Rev Mol Med 2008; 10: e19.
  Article PubMed PubMed Central Google Scholar
• Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003; 22: 2021–2033.
  Article CAS PubMed Google Scholar
• Lin T, Ponn A, Hu X, Law BK, Lu J . Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition. Oncogene 2010; 29: 4896–4904.
  Article CAS PubMed PubMed Central Google Scholar
• Chen WD, Eshleman JR, Aminoshariae MR, Ma AH, Veloso N, Markowitz SD et al. Cytotoxicity and mutagenicity of frameshift-inducing agent ICR191 in mismatch repair-deficient colon cancer cells. J Natl Cancer Inst 2000; 92: 480–485.
  Article CAS PubMed Google Scholar
• Zientek-Targosz H, Kunnev D, Hawthorn L, Venkov M, Matsui S, Cheney RT et al. Transformation of MCF-10A cells by random mutagenesis with frameshift mutagen ICR191: a model for identifying candidate breast-tumor suppressors. Mol Cancer 2008; 7: 51.
  Article PubMed PubMed Central Google Scholar
• Milde T, Oehme I, Korshunov A, Kopp-Schneider A, Remke M, Northcott P et al. HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth. Clin Cancer Res 2010; 16: 3240–3252.
  Article CAS PubMed Google Scholar
• He P, Liang J, Shao T, Guo Y, Hou Y, Li Y . HDAC5 promotes colorectal cancer cell proliferation by up-regulating DLL4 expression. Int J. Clin Exp Med 2015; 8: 6510–6516.
  CAS Google Scholar
• Nagasawa S, Sedukhina AS, Nakagawa Y, Maeda I, Kubota M, Ohnuma S et al. LSD1 overexpression is associated with poor prognosis in basal-like breast cancer, and sensitivity to PARP inhibition. PLoS One 2015; 10: e0118002.
  Article PubMed PubMed Central Google Scholar
• Piao L, Suzuki T, Dohmae N, Nakamura Y, Hamamoto R . SUV39H2 methylates and stabilizes LSD1 by inhibiting polyubiquitination in human cancer cells. Oncotarget 2015; 6: 16939–16950.
  Article PubMed PubMed Central Google Scholar
• Shi YJ, Matson C, Lan F, Iwase S, Baba T, Shi Y . Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell. 2005; 19: 857–864.
  Article CAS PubMed Google Scholar
• Greco TM, Yu F, Guise AJ, Cristea IM . Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. Mol Cell Proteom 2011; 10: M110.004317.
  Article Google Scholar
• Diefenbacher ME, Popov N, Blake SM, Schulein-Volk C, Nye E, Spencer-Dene B et al. The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer. J Clin Invest 2014; 124: 3407–3418.
  Article CAS PubMed PubMed Central Google Scholar
• Popov N, Wanzel M, Madiredjo M, Zhang D, Beijersbergen R, Bernards R et al. The ubiquitin-specific protease USP28 is required for MYC stability. Nat Cell Biol 2007; 9: 765–774.
  Article CAS PubMed Google Scholar
• Zhang D, Zaugg K, Mak TW, Elledge SJ . A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response. Cell 2006; 126: 529–542.
  Article CAS PubMed Google Scholar
• Sen N, Kumari R, Singh MI, Das S . HDAC5, a key component in temporal regulation of p53-mediated transactivation in response to genotoxic stress. Mol Cell 2013; 52: 406–420.
  Article CAS PubMed Google Scholar
• Traynor AM, Dubey S, Eickhoff JC, Kolesar JM, Schell K, Huie MS et al. Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II study. J Thorac Oncol 2009; 4: 522–526.
  Article PubMed PubMed Central Google Scholar
• Luu TH, Morgan RJ, Leong L, Lim D, McNamara M, Portnow J et al. A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study. Clin Cancer Res 2008; 14: 7138–7142.
  Article CAS PubMed PubMed Central Google Scholar
• Modesitt SC, Sill M, Hoffman JS, Bender DP . A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2008; 109: 182–186.
  Article CAS PubMed Google Scholar
• Blumenschein GR Jr, Kies MS, Papadimitrakopoulou VA, Lu C, Kumar AJ, Ricker JL et al. Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer. Invest New Drugs 2008; 26: 81–87.
  Article CAS PubMed Google Scholar
• Shaw PG, Chaerkady R, Wang T, Vasilatos S, Huang Y, Van Houten B et al. Integrated proteomic and metabolic analysis of breast cancer progression. PLoS ONE 2013; 8: e76220.
  Article CAS PubMed PubMed Central Google Scholar
• Varghese F, Bukhari AB, Malhotra R, De A . IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS ONE 2014; 9: e96801.
  Article PubMed PubMed Central Google Scholar
• Ishibashi H, Suzuki T, Suzuki S, Moriya T, Kaneko C, Takizawa T et al. Sex steroid hormone receptors in human thymoma. J Clin Endocrinol Metab 2003; 88: 2309–2317.
  Article CAS PubMed Google Scholar
• Huang Y, Hager ER, Phillips DL, Dunn VR, Hacker A, Frydman B et al. A novel polyamine analog inhibits growth and induces apoptosis in human breast cancer cells. Clin Cancer Res 2003; 9: 2769–2777.
  CAS PubMed PubMed Central Google Scholar
• Huang Y, Keen J, Pledgie A, Marton L, Zhu T, Sukumar S et al. Polyamine analogues down-regulate estrogen receptor alpha expression in human breast cancer cells. J Biol Chem 2006; 281: 19055–19063.
  Article CAS PubMed Google Scholar
• Katz TA, Vasilatos SN, Harrington E, Oesterreich S, Davidson NE, Huang Y . Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells. Breast Cancer Res Treat 2014; 146: 99–108.
  Article CAS PubMed Google Scholar
• Huang Y, Vasilatos SN, Boric L, Shaw PG, Davidson NE . Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells. Breast Cancer Res Treat 2012; 131: 777–789.
  Article CAS PubMed Google Scholar